Tactile Systems' Q4 earnings surpassed investor expectations, reporting $0.46 per share and a significant 21% increase in sales to $103.59 million. This strong performance highlights the company's successful lymphedema and airway clearance product lines, which could further boost investor confidence and stock performance.
TCMD reported Q3 earnings of 36 cents, surpassing estimates by 19 cents. Quarterly sales reached $85.755 million, exceeding expectations of $79.306 million. FY2025 sales guidance raised to $317-$321 million from $310-$315 million. Shares soared 38.1% post-earnings, closing at $21.78. Analysts have adjusted price targets, with Lake Street maintaining a Buy rating.